Abstract: Methods of treating a subterranean formation including providing a treatment fluid comprising a brine base fluid and an anionic carboxylated polysaccharide, wherein the brine base fluid comprises a concentration of salt in the range of from about 30,000 ppm to saturation and a pH in the range of from about 4 to about 8, and wherein the anionic carboxylated polysaccharide is present in the range of from about 0.05% to about 2% by weight of the treatment fluid; and introducing the treatment fluid into the subterranean formation.

Abstract: Methods of treating a subterranean formation including providing a treatment fluid comprising a brine base fluid and an anionic carboxylated polysaccharide, wherein the brine base fluid comprises a concentration of salt in the range of from about 30,000 ppm to saturation and a pH in the range of from about 4 to about 8, and wherein the anionic carboxylated polysaccharide is present in the range of from about 0.05% to about 2% by weight of the treatment fluid; and introducing the treatment fluid into the subterranean formation.

Abstract: A method of treating a well including the steps of: (A) treating a first aqueous fluid comprising seawater with electrocoagulation to obtain a second aqueous fluid, wherein the second aqueous fluid has a reduced concentration of magnesium ions relative to the original concentration of magnesium ions in the first aqueous fluid; (B) forming a treatment fluid comprising: (i) an aqueous phase, wherein the aqueous phase comprises the second aqueous fluid, and (ii) a viscosity-increasing agent in the aqueous phase; and (C) introducing the treatment fluid into a well. The aqueous phase can have a pH of at least about 9 or the treatment fluid can be introduced into a well at a design temperature of at least about 93° C. (200° F.).